Register Financial Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.2K Sell
19,800
-500
-2% -$1.82K 0.02% 294
2026
Q1
$80.2K Sell
20,300
-500
-2% -$2.52K 0.03% 266
2025
Q4
$141K Sell
20,800
-1,500
-7% -$10.5K 0.05% 221
2025
Q3
$156K Hold
22,300
0.06% 211
2025
Q2
$136K Hold
22,300
0.06% 215
2025
Q1
$169K Hold
22,300
0.09% 181
2024
Q4
$215K Sell
22,300
-11,500
-34% -$89.6K 0.11% 168
2024
Q3
$200K Hold
33,800
0.1% 168
2024
Q2
$234K Hold
33,800
0.12% 153
2024
Q1
$260K Sell
33,800
-4,000
-11% -$32.2K 0.14% 143
2023
Q4
$332K Sell
37,800
-2,500
-6% -$18.3K 0.22% 109
2023
Q3
$294K Sell
40,300
-5,242
-12% -$39K 0.22% 102
2023
Q2
$301K Sell
45,542
-121,700
-73% -$620K 0.21% 104
2023
Q1
$570K Buy
167,242
+50,542
+43% +$196K 0.45% 62
2022
Q4
$324K Buy
+116,700
New +$349K 0.21% 108

Other funds holding MDXG

Register Financial Advisors's MDXG Position: Q2 2026 in Review

Register Financial Advisors reduced its MiMedx Group (MDXG) stake by 2.5% in Q2 2026, selling an estimated $1.82K and leaving 19,800 shares worth $76.2K. The position accounts for 0.02% of the portfolio, ranked #294.

Register Financial Advisors first reported a position in MDXG in Q4 2022 and has held it in 15 quarters since. The position peaked at $570K in Q1 2023. 51 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Register Financial Advisors held 19,800 shares of MiMedx Group worth $76.2K as of Q2 2026.
  • Register Financial Advisors sold 500 MiMedx Group shares in Q2 2026, an estimated $1.82K.
  • MiMedx Group made up 0.02% of Register Financial Advisors's portfolio in Q2 2026, its #294 holding.
  • Register Financial Advisors first reported a position in MiMedx Group in Q4 2022 and has held it in 15 quarters since.
  • Register Financial Advisors's MiMedx Group position peaked at $570K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Register Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.